Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003493014 | SCV004235222 | uncertain significance | Hemolytic anemia due to glutathione reductase deficiency | 2023-05-18 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004364883 | SCV004880883 | uncertain significance | not specified | 2023-11-29 | criteria provided, single submitter | clinical testing | The c.476A>T (p.Q159L) alteration is located in exon 4 (coding exon 4) of the GSR gene. This alteration results from a A to T substitution at nucleotide position 476, causing the glutamine (Q) at amino acid position 159 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Mayo Clinic Laboratories, |
RCV004790574 | SCV005409430 | uncertain significance | not provided | 2023-06-28 | criteria provided, single submitter | clinical testing | BP4, PM2_moderate |